Rocket Doctor AI, Health Cities and CAN Health Network Partner to Advance AI-Powered Clinical Decision Support in Alberta

Rhea-AI Summary

Rocket Doctor AI (OTC:AIRDF) announced a partnership with the CAN Health Network and Health Cities to pilot an AI-powered Clinical Decision Support System (CDSS) in Alberta.

The pilot runs from November 2025 to March 2026, will deploy at up to four primary care sites with about 20 clinicians, and phases include chatbot intake, real-time clinician support, and EMR integration. The company cites an expected 25–40% reduction in intake time, Canadian-hosted data centres compliant with HIPAA, PIPEDA, and Alberta HIA, and a Commercialization Project Agreement dated 11/12/2025. The project aims to validate CDSS performance and potentially scale across Alberta’s ~4,400 providers.

Positive

• Pilot scope: up to 4 primary care sites and ~20 clinicians
• Efficiency target: 25–40% reduction in physician intake time
• Compliance: platform hosted in Canadian data centres aligned with HIPAA/PIPEDA/HIA
• Scale potential: architecture designed to reach ~4,400 Alberta providers

Negative

• Limited pilot size: initial deployment confined to up to four sites
• Agreement termination: Commercialization Project Agreement can be ended by either party on notice

Key Figures

Pilot timeline November 2025 to March 2026 Duration of Alberta CDSS project

Primary care sites Up to 4 sites Initial Alberta CDSS rollout

Participating clinicians Approximately 20 clinicians Clinician involvement in pilot

Intake time reduction 25–40% reduction Target decrease in physician intake time

Alberta providers 4,400 providers Potential future CDSS scale across province

Agreement date 12 November 2025 Commercialization Project Agreement execution

Market Reality Check

$0.5400 Last Close

Volume Volume 31,256 is below the 20-day average of 98,154, suggesting limited pre-news participation. low

Technical Price at 0.57455 is above the 200-day MA of 0.55, indicating a pre-news uptrend bias.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 08	AI partnership pilot	Positive	-5.7%	Alberta CDSS pilot with CAN Health and Health Cities using GLM.
Dec 05	Mgmt & equity awards	Neutral	-5.7%	CFO transition plus grants of options and RSUs to stakeholders.
Dec 04	Education partnership	Positive	+2.0%	Strategic partnership with TMU to expand digital clinical education.
Dec 02	Q3 results & AI	Positive	+1.2%	Q3 revenue growth, strong margin, funding, and AI-driven U.S. expansion.
Nov 26	AI platform visibility	Positive	+9.6%	CEO presentations highlighting AI Nurse and GLM with Google technology.

Pattern Detected

Recent AI and partnership announcements generally saw positive or mixed price responses, but the current AI partnership and a recent compensation/management release both coincided with notable declines, indicating occasional selloffs on otherwise constructive news.

Recent Company History

Over the last few weeks, Rocket Doctor AI has reported several milestones. A Q3 2025 update highlighted revenue growth, high gross margin, and additional funding. Subsequent AI- and partnership-focused releases, including a collaboration with Toronto Metropolitan University and visibility at Google and Heal.LA events, emphasized platform expansion and education. The new Alberta CDSS partnership, detailed in today’s AI-tagged article dated Dec 8, 2025, extends this strategy by piloting GLM-driven clinical support in real-world primary care settings.

Market Pulse Summary

The stock moved -5.7% in the session following this news. A negative reaction despite constructive AI news fits prior instances where seemingly positive updates were followed by downside, such as the recent decline after compensation and management changes. The Alberta CDSS pilot still extends GLM deployment across up to 4 sites and about 20 clinicians, with ambitions to reach 4,400 providers. Investors assessing such weakness may focus on funding needs, adoption risk, and the company’s loss profile from earlier financial updates.

Key Terms

clinical decision support system medical

"deliver an AI-powered Clinical Decision Support System (CDSS) in collaboration"

A clinical decision support system is software that analyzes a patient’s information and gives clinicians timely, patient-specific guidance—such as alerts, diagnostic suggestions, or dosing recommendations—much like a GPS guiding a driver. Investors watch these systems because they can speed care, reduce mistakes, lower costs, and create recurring software revenue, but they also bring regulatory, integration, and liability considerations that affect a healthcare company’s growth and profitability.

electronic medical records technical

"ultimately integration with electronic medical records (EMRs)."

Electronic medical records are digital versions of a patient’s health file created and kept by a single healthcare provider, containing diagnoses, medications, lab results, treatment notes and billing codes. They matter to investors because the software and services that create, store and analyze these records can generate steady revenue, lower provider costs, enable faster decision-making and carry regulatory and cybersecurity risks; think of EMRs as the digital filing cabinet that underpins many healthcare operations.

hipaa regulatory

"data centres, aligned with HIPAA, PIPEDA, and Alberta’s Health Information Act"

A U.S. law that sets rules for keeping individuals’ health information private and secure, and for how that information can be shared. Think of it as a mandatory lock-and-key system for medical records that hospitals, insurers, and tech vendors must use. Investors care because failing to follow these rules can lead to big fines, costly remediation, loss of business access to patient data, and reputational damage that can hurt a company’s finances and growth prospects.

pipeda regulatory

"data centres, aligned with HIPAA, PIPEDA, and Alberta’s Health Information Act"

A federal Canadian law that sets rules for how organizations collect, use and disclose personal information in the course of commercial activity. Think of it as a privacy rulebook: companies must get consent, protect data, and be transparent about their practices. For investors, PIPEDA matters because non‑compliance can lead to fines, legal costs, lost customers and reputational damage that can hurt revenue and share value.

health information act regulatory

"aligned with HIPAA, PIPEDA, and Alberta’s Health Information Act (HIA)."

A health information act is a law that sets clear rules for how personal medical and health data are collected, stored, shared and protected. Investors should care because these laws determine what data businesses can use, create compliance costs and potential fines, and influence the value and marketability of health-related products — like a lockbox and rulebook that shapes access, risk and competitive advantage.

AI-generated analysis. Not financial advice.

• Rocket Doctor AI joins forces with the CAN Health Network to deliver an AI-powered Clinical Decision Support System (CDSS) in collaboration with Health Cities Alberta.
  
  
• Initial rollout will take place at up to four primary care sites serving up to 20 physicians, running from December 2025 to March 2026.
  
  
• The project aims to reduce intake time by 25–40% and improve diagnostic accuracy using Rocket Doctor AI’s proprietary Global Library of Medicine (GLM).
  
  
•  Goal to eventually expand CDSS province-wide across Alberta

Vancouver, BC, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced a new partnership with the CAN Health Network to test its AI-powered Clinical Decision Support System (CDSS) in collaboration with Health Cities. The project will launch at up to four primary care sites in Alberta to help physicians deliver faster, evidence-based, and more efficient care.

The program was developed in accordance with Health Cities’ need for an integrated, AI-powered solution capable of analyzing diverse data sources, automating routine tasks, and delivering real-time clinical recommendations. The project, running from November 2025 to March 2026, involves approximately 20 clinicians and aims to set the foundation for a potential full provincial rollout in 2026. As a CAN Health Network Primary Care Edge, Health Cities creates an environment where innovative solutions can be co-developed, validated, and adopted to address real-world health challenges.

The initiative rolls out in three phases, beginning with AI-powered patient intake through a website-embedded chatbot, followed by real-time clinician support during visits, and ultimately integration with electronic medical records (EMRs). Rocket Doctor AI’s Global Library of Medicine (GLM) is a clinically-validated decision engine developed with input from hundreds of physicians to assist providers with triage, differential diagnosis, and evidence-based care planning.

This project comes at a critical time for Alberta’s healthcare system, where staffing shortages, limited access to primary care, and increasing patient loads continue to strain clinics across the province. Recent data shows that one in five Albertans lacks a family physician, with many communities facing long wait times for basic care. This project aims to directly address these challenges by supporting clinicians with intelligent, AI-driven tools that improve efficiency and patient access.

Key anticipated outcomes include a 25-40% reduction in physician intake time, as well as improved patient satisfaction through faster and clearer communication. The CDSS is also expected to significantly reduce physicians’ administrative workload, including less time on charting, documentation, and billing.

“Partnering with CAN Health and Health Cities represents an important milestone for Rocket Doctor AI,” said Dr. Essam Hamza, CEO of Rocket Doctor AI. “Our mission is to empower healthcare providers with tools that improve patient outcomes and restore time for meaningful patient interactions. This collaboration will help demonstrate how AI can directly support physicians on the frontlines of care.”

Rocket Doctor AI’s platform will be hosted in secure, Canadian-based data centres, aligned with HIPAA, PIPEDA, and Alberta’s Health Information Act (HIA). The modular system architecture ensures future growth, with the capability to scale across Alberta’s 4,400 providers and beyond.

“This collaboration will allow Alberta’s healthcare community to evaluate how AI can improve system efficiency and clinical decision-making in real-world settings,” said Dr. Dante Morra, Founder and CEO of the CAN Health Network. “By starting with intake and decision support, we can scale to support thousands of providers across the province.”

This project is made possible through funding and support from the CAN Health Network, a federally funded initiative designed to help Canadian companies scale innovative healthcare solutions domestically. The partnership underscores Rocket Doctor AI’s commitment to advancing equitable access to care, supporting overburdened clinicians, and modernizing healthcare delivery through responsible AI innovation.

A Commercialization Project Agreement was entered into by the parties on 12th November 2025. The Agreement details the intent of the parties to collaborate in jointly delivering a Commercialization Project. Either party may propose amendments or terminate this Agreement upon written notice.

About Health Cities

Health Cities is an independent Canadian not-for-profit dedicated to advancing healthcare by co-creating practical, scalable solutions with partners across the health continuum. We engage clinicians, innovators, industry partners, and governments to strengthen care delivery and improve health outcomes for individuals and their communities. 

We validate new innovations and care models in real-world environments to de-risk adoption and enable effective integration into existing services. Health Cities helps create sustainable, accessible, and future-ready models that can keep pace with an evolving healthcare landscape.  

For more information, visit www.healthcities.ca.

For media inquiries, contact: Elizabeth Kendall, elizabeth@healthcities.ca

About CAN Health Network

Launched in 2019, the CAN Health Network is a national platform dedicated to accelerating the adoption of Canadian technology in health care. By connecting health technology innovators with hospitals, clinics, and care settings across the country, CAN Health facilitates commercialization projects that match proven Canadian solutions with real-world operational needs. This approach fosters collaboration, drives better patient outcomes, and supports a thriving domestic innovation ecosystem. The Membership Program builds on this proven model, offering even more targeted support to help companies scale and succeed.

For more information: https://canhealthnetwork.ca/
For media inquiries contact:  jennifer.coulman@canhealthnetwork.ca

About Rocket Doctor AI Inc.

Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.

To learn more about Rocket Doctor AI Inc’s products and services, contact:

www.rocketdoctor.ai  or email: info@rocketdoctor.ai

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai

For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321

Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io

Cautionary Statements

This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

FAQ

What is Rocket Doctor AI (AIRDF) piloting in Alberta from November 2025 to March 2026?

A CDSS pilot deploying an AI chatbot intake, real-time clinician support, and planned EMR integration at up to four primary care sites with ~20 clinicians.

How much intake time reduction does Rocket Doctor AI (AIRDF) expect in the Alberta pilot?

The company cites an expected 25–40% reduction in physician intake time during the pilot.

When was the Commercialization Project Agreement for the AIRDF pilot signed?

The parties entered the Commercialization Project Agreement on 12 November 2025.

Will Rocket Doctor AI (AIRDF) host patient data in Canada for the Alberta pilot?

Yes; the platform will be hosted in Canadian-based data centres and aligned with HIPAA, PIPEDA, and Alberta HIA.

Could the AIRDF commercialization project be stopped before province-wide rollout?

Yes; the Agreement allows either party to propose amendments or terminate upon written notice.